Eli Lilly Animal Health Products — Revenue increased by 2.6% to $19.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 55.5%, from $12.73B to $19.80B. Over 4 years (FY 2021 to FY 2025), Animal Health Products — Revenue shows an upward trend with a 23.2% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or demand for the company's veterinary products, while a decrease may signal competitive pressure or reduced spending on animal health services.
This metric represents the total net sales generated from the company's portfolio of animal health products, including p...
Comparable to animal health segments at diversified life sciences or pharmaceutical companies, where revenue is driven by pet ownership trends and agricultural productivity.
lly_segment_animal_health_products_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.74B | $6.77B | $8.00B | $7.81B | $6.49B | $6.94B | $7.30B | $6.96B | $8.31B | $9.50B | $9.35B | $8.77B | $11.30B | $11.44B | $13.53B | $12.73B | $15.56B | $17.60B | $19.29B | $19.80B |
| QoQ Change | — | +0.5% | +18.1% | -2.4% | -16.9% | +7.0% | +5.2% | -4.7% | +19.4% | +14.3% | -1.5% | -6.3% | +28.9% | +1.2% | +18.3% | -5.9% | +22.2% | +13.1% | +9.6% | +2.6% |
| YoY Change | — | — | — | — | -3.7% | +2.5% | -8.7% | -10.9% | +28.1% | +36.8% | +28.1% | +26.0% | +36.0% | +20.4% | +44.7% | +45.2% | +37.6% | +53.9% | +42.6% | +55.5% |